Results: Four overexpressed and mutated tumor antigens associated with antigen presentation and poor prognosis were identified in ESCC, including NLRC5, FCRL4, TMEM229B, and LCP2. This evidence concerns the gene FCRL4 and esophageal squamous cell carcinoma.